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Three germ layersa b s t r a c t
Stem cell research has gathered immense attention in the past decade due to the remarkable ability of
stem cells for self-renewal and tissue-speciﬁc differentiation. Despite having numerous advancements
in stem cell isolation and manipulation techniques, there is a need for highly reliable probes for the
speciﬁc detection of live stem cells. Herein we developed a new ﬂuorescence probe (CDy9) with high
selectivity for mouse embryonic stem cells. CDy9 allows the detection and isolation of intact stem cells
with marginal impact on their function and capabilities.
 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license
(http://creativecommons.org/licenses/by/4.0/).Stem cells are unique cell populations found in almost every
multi-cellular organism with the capacity to give rise to many dif-
ferent types of cells in the body during early development and
growth.1–3 Embryonic stem cells (ESC) are isolated from very
young embryos (3.5 days-old) and found in the inner cell mass of
blastocysts (i.e., embryos consisting of around 100 cells) of fertil-
ized eggs.3 ESC are pluripotent as they are able to remain undiffer-
entiated in vitro and then differentiate into all the different cell
types of the three germ layers when given the correct cues.4
Despite the potential of stem cells for the treatment of complex
diseases, there are still no effective ways to detect stem cells
in vivo or ex vivo. This is mainly due to their heterogenetic nature
and unpredictable pattern of proliferation and differentiation in
ex vivo cultures.2 Current characterization methods for stem cells
mainly rely on immunohistochemistry using protein markers and
subsequent treatment with secondary antibodies.5 These methods
typically require ﬁxation of the cells with paraformaldehyde,
which hampers the application of the cells in subsequent studies.
Therefore, there is a need for new strategies that allow direct
detection and monitoring of stem cells in a non-invasive manner.Fluorescence imaging offers many advantages for non-invasive
cell tracking. On top of being rapid and extremely sensitive, ﬂuo-
rescent probes are compatible with a broad range of instrumenta-
tion.6 In the last decade, considerable effort has been put into the
development of highly sensitive ﬂuorescent molecular imaging
tools7,8 and genetically encoded ﬂuorescent protein reporters.9
These reporters have proven their exceptional value in numerous
biological studies, but entail some disadvantages, such as the
potential interference with protein function and the need for
genetic manipulation. An alternative to encoded protein reporters
for labeling cells in vivo are small molecule ﬂuorescent probes.10,11
Our group has pioneered the development of ﬂuorescent probes
using the Diversity Oriented Fluorescence Library Approach
(DOFLA). DOFLA exploits the power of combinatorial chemistry
to derivatize ﬂuorescent scaffolds with several functional groups
and generate libraries of structurally and spectrally diverse ﬂuores-
cent molecules.12 To date, DOFLA has been an excellent source for
the discovery of unique sensors and probes, especially for targets
with limited molecular information.13–15 In the context of stem cell
probe development, three ﬂuorescent probes for mouse embryonic
stem cells (mESC) have been previously identiﬁed by the DOFLA:
compound of designation yellow 1 (CDy1), compound of designa-
tion green 4 (CDg4) and compound designation of blue 8
(CDb8).16–18 CDy1was the ﬁrst mESC-staining probe to be reported
from DOFLA, and it is a rosamine-based ﬂuorophore that labels
Figure 1. CDy9 is a novel and versatile mESC-speciﬁc ﬂuorescent probe. (a)
Chemical structure of CDy9. (b) CDy9 selectively stains mESC over MEF. Both mESC
and MEF were incubated with 1 lM CDy9 and imaged under the ﬂuorescence
microscope after 1 h. Scale bar: 25 lm. (c) Flow cytometry analysis of mESC and
MEF after incubation with CDy9. The ﬂuorescence intensity of mESC upon
treatment with CDy9 is brighter than in MEF (right dot plot) and in unstained
mESC (left dot plot).
Figure 2. Isolation of CDy9-stained cells and analysis by single cell PCR. (a) CDy9 select
CDy9 and imaged under the ﬂuorescence microscope after 1 h. Scale bar: 100 lm. (b) FA
CDy9 ﬂuorescence intensity and Y-axis refers to the side scattering (SSC), an indication
populations. (c) Table of primers used to distinguish pluripotent (red) from differentiated
CDy9-dim populations. CDy9-bright cells display an up-regulation of pluripotent genes (m
like).
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can stain mouse iPSC in early stages of development, allowing early
detection and characterization of these cells.19,20 CDb8 was
reported as a mESC-staining probe with short emission wave-
lengths (kexc./kem.:369 nm/487 nm) discovered upon the combina-
torial derivatization of a xanthone ﬂuorescent scaffold. Finally,
CDg4 is a chalcone derivative that labels mESC upon binding to
the glycogen molecules present on the surface of mESC. Notably,
despite the identiﬁcation of these three ﬂuorescent probes with
preferential labeling of mESC over mouse embryonic ﬁbroblasts
(MEF), we observed that CDy1, CDb8 and CDg4 can also stain dif-
ferentiated cells from various lineages (i.e., ectoderm, endoderm
and mesoderm) and therefore cannot be used for direct and
unequivocal identiﬁcation and isolation of mESC.
Herein we report the identiﬁcation of a ﬂuorescent small mole-
cule with high speciﬁcity for mESC and marginal staining in a
whole range of cells derived from different lineages of the three
germ layers. From our high-throughput cell imaging screening,
we identiﬁed CDy9 (compound of designation yellow 9, kexc./kem.:
563 nm/578 nm) as a ﬂuorescent small molecule with high selec-
tivity for mESC over MEF (Fig. 1). CDy9 was synthesized by deriva-
tization of the 4,4-diﬂuoro-4-bora-3a,4a-diaza-s-indacene
(BODIPY) ﬂuorescent scaffold using solid-phase synthesis (see
Supporting information for synthetic and characterization data).21
In order to identify the chemical groups of CDy9 that were respon-
sible for its preferential labeling of mESC, we evaluated the ﬂuores-
cence staining of mESC and MEF upon incubation with twoively stains mESC in co-cultures with MEF. Co-cultures were incubated with 1 lM
CS analysis of co-cultured mESC and MEF after CDy9 staining. X-Axis refers to the
of the size of the cells. FACS enabled the isolation of CDy9-bright and CDy9-dim
(blue) cells. (d) Heatmap obtained from single cell PCR analysis of CDy9-bright and
ESC-like) and CDy9-dim cells show an up-regulation of differentiated genes (MEF-
Figure 3. Diagram of pluripotent stem cell differentiation and cell panel test. (a) mESC are derived from the inner cell mass of a blastocyst and able to differentiate into all
cells types of the three primary germ layers: mesoderm (e.g., muscle, blood), endoderm (e.g., pancreas), ectoderm (e.g., neurons). (b) CDy9 staining in different stem cells:
mESC, mouse mesenchymal stem cells (mMSC) and mouse neuronal stem cells (NS5). Scale bar: 200 lm. (c) CDy9 staining in different pancreatic cells (endoderm). (d) CDy9
staining in different muscle and blood cells (mesoderm). (e) CDy9 staining in different neuronal cells (ectoderm). In all cases, cells were incubated with 1 lM CDy9 and
Hoechst 33342 (nuclear counterstain) and imaged under the ﬂuorescence microscope after 1 h.
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tion of both the free-amine and the acetyl derivative conﬁrmed
CDy9 as the most discriminatory compound of the family, indicat-
ing the relevance of the chloroacetyl group and highlighting the
importance of acetylation of the meso aniline group of CDy9 to
achieve selectivity for mESC over MEF. CDy9 is a highly versatile
probe that enabled mESC detection and isolation using other ﬂuo-
rescence-based techniques, such as ﬂow cytometry. As shown in
Figure 1c, CDy9 showed a signiﬁcantly brighter signal in mESC
when compared to MEF and to unstained mESC.
In view of the different staining properties of CDy9 in mESC and
MEF, we used our probe in co-cultures to evaluate its potential to
simultaneously discriminate these two cell types. As shown in
Figure 2a, CDy9 brightly stained mESC in co-cultures with MEF.Furthermore, in order to validate our observation, we used
ﬂuorescence-assisted cell sorting (FACS) to isolate the two cell
populations according to their side scattering (SSC) and
CDy9-staining. We named the two populations as CDy9-dim and
CDy9-bright cells, and analyzed their gene expression proﬁles by
single cell PCR (Fig. 2d). Single cell PCR enables the characteriza-
tion of rare events and small populations of cells with extremely
high sensitivity.22 The gene expression proﬁle of 48 individual
brightly-stained cells and 48 individual dimly-stained cells was
determined by a total of 33 primers from the TaqMan Gene
Expression Assay. Speciﬁcally, we selected 21 primers that are
characteristic of pluripotent cells as well as 12 primers for differen-
tiated cells. As shown in Figure 2c, the 21 selected genes (red) are
upregulated in ESC and involved in stem cell initiation, maturation
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upregulated in differentiated cells (e.g., MEF) and widely consid-
ered as mesenchymal and differentiation markers.
We collected single cell PCR data for the two differently CDy9-
stained populations, and plotted the resulting GAPDH-normalized
values in a heatmap (Fig. 2d). From our heatmap, we concluded
that CDy9-bright cells displayed a general trend in upregulation
of pluripotent genes while CDy9-dim cells showed a tendency
towards upregulating genes that are characteristic of differentiated
cells. The heatmap plot also illustrates that ESC-representative
genes (e.g., Oct4 (1), Esg1 (2)) showed uniformly high expression
levels in CDy9-bright cells while the differentiation marker FN1
(33) was highly upregulated in almost all CDy9-dim cells. Further
analysis by principle component analysis (PCA) corroborated the
clear differences between CDy9-bright and CDy9-dim cells, and
their correspondence to the gene expression proﬁles of mESC and
MEF, respectively, (Fig. S2). Altogether, the results from both the
heatmap and the PCA analysis validate the potential of CDy9 as a
ﬂuorescent tool to speciﬁcally label mESC in cell mixtures.
Next we assessed whether CDy9 could stain mouse iPSC
obtained from MEF from transgenic mice expressing green ﬂuores-
cent protein (GFP) under the Oct4 promoter control. GFP-express-
ing mouse iPSC were cultured and allowed to differentiate to
generate complex mixtures of stem-like and differentiated cells.23
When we added CDy9 to these complex mixtures, we observed
that CDy9 speciﬁcally stained non-differentiated mouse iPSC as
observed from the co-localization with the GFP signal (Fig. S3a).
Furthermore, we differentiated GFP-expressing mouse iPSC into
mesoderm, ectoderm and endoderm lineages conﬁrmed by
immunohistochemistry with anti-SMA, anti-Nestin and anti-
Sox17, respectively. CDy9 and GFP signals were completely lost
upon differentiation, which asserts the high selectivity of CDy9
for mESC (Fig. S3b).
ESCs have the ability to prolong their self-renewal or differenti-
ate depending on the signals from their microenvironment.24 In
order to evaluate the ability of CDy9 to selectively label mESC with
marginal staining in differentiated cells, we screened our probe in
several stem cells as well as in differentiated cells obtained from
embryoid bodies. We included stem cell populations (e.g., mes-
enchymal stem cells and neural stem cells) in addition to mESC.
Moreover, our panel included a wide range of cells from all three
different germ layers since mESC can be readily differentiated into
ectoderm, endoderm and mesoderm lineages (Fig. 3a).25–27
The endoderm is the innermost layer of the embryo. This layer
consists of cells from the respiratory tract and the glands that are
associated with the bladder, urethra and the gastrointestinal tract.
We selected three cell types from this lineage, namely pancreatic
alpha, beta and acinar cells (Fig. 3c). The mesoderm is the middle
layer that leads to the formation of muscles, bones, blood and con-
nective tissues. Muscle C2C12 cells as well as T and B lymphocytes
were chosen as representative cells from the mesoderm lineage
(Fig. 3d). Finally, the ectoderm is the outermost layer of the three
germ layers, which gives rise to cells from the central nervous sys-
temandepidermal tissues (e.g., skin). Our panel includedNS5differ-
entiated astrocytes, primary neurons and mixed glial, which
contains a mixture of microglia, astrocytes and oligodendrocytes
(Fig. 3e). Notably, CDy9 selectively stained only mESC with no
detectable ﬂuorescence emission in any of the other 11 cell types
screened. We also compared the selectivity proﬁle of CDy9 to some
of our previous mESC-staining ﬂuorescent probes, namely CDy1,
CDg4 and CDb8. As shown in Figures S4–S6, while all these three
compounds showed a clear and preferential staining in mESC, they
also stained cells from some differentiated lineages (CDy1: endo-
derm and ectoderm; CDg4: endoderm, CDb8: endoderm).Taken together, our results validate CDy9 as a highly selective
ﬂuorescent probe for the detection and isolation of mESC using ﬂu-
orescence microscopy and ﬂow cytometry. In view of the potential
of stem cells as invaluable tools for biological understanding,
cell-based therapies and the development of novel drug discovery
platforms,28 we believe that CDy9will accelerate those studies as a
non-invasive biotechnological tool for the preparation, puriﬁcation
and characterization of mESC.
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